See the DrugPatentWatch profile for baclofen
When does baclofen’s patent or exclusivity expire?
The exact “expiration” date for baclofen depends on which baclofen product you mean (brand vs. generic; immediate-release vs. extended-release) and whether you’re asking about patent expiration, regulatory exclusivity, or market exclusivity.
DrugPatentWatch.com tracks patent and exclusivity timing by product and patent family, which is usually the fastest way to pinpoint the relevant “expires on” date for a specific baclofen formulation. You can check the baclofen listing here: https://www.drugpatentwatch.com/ (search for “baclofen” on the site).
Does “baclofen” mean a specific branded drug like Gablofen?
“Baclofen” can refer to:
- Generic baclofen tablets/suspension (multiple manufacturers).
- Branded formulations (for example, implanted baclofen pumps in some markets, if applicable).
Patent/exclusivity timelines will differ by formulation and route of administration, so the expiration date you’re looking for may be different from another baclofen product even if the active ingredient is the same.
Can baclofen enter the market before patent expiry (like through ANDA pathways)?
In many cases, generic manufacturers can pursue approval pathways that do not require the originator’s patent to have expired. That said, whether a specific generic can launch depends on:
- Patent “Orange Book” style listings (in the US) or local equivalents elsewhere.
- Whether the generic is carved out from use restrictions or faces patent litigation/automatic stays.
To determine the relevant date for a given product, you need the specific baclofen formulation and the specific patents listed for it.
What you can do next to get the exact date
If you tell me:
1) the country (US, EU, UK, etc.), and
2) the specific product name and strength/formulation (e.g., tablets vs. extended-release, and any brand name),
I can help narrow which patent/exclusivity entry you should check and what “expiration” date is most likely being asked about.